Callio Therapeutics

Developer of multi-payload antibody-drug conjugates for cancer treatment

placeSeattle, Washington, United States calendar_todayFounded 2024 language calliotx.com

Social engagement

Social engagement: 4.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Frazier Life Sciences.

Investor typeCountShare
Venture capital770%
Other / undisclosed330%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

10 Feb 2026 · Director / Senior Director, Clinical Pharmacology & Translational Medicine · Seattle

11 Oct 2025 · Director / Senior Director, Clinical Pharmacology · Seattle

Based on job postings tracked across public sources.

Recent activity

9 Jun 2026
Event
3rd BioCentury Grand Rounds
3 Jun 2026
Event
BioCentury Grand Rounds
31 May 2026
Event
ASCO26
Coming soon